Abeona Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Abeona Therapeutics

29/03/2023 14:14

* Abeona Therapeutics Inc  ABEO.OQ  reported quarterly
adjusted
earnings of $1.53​​ per share for the quarter ended in December.
The mean expectation of two analysts for the quarter was for a
loss of 75 cents per share.
    * Revenue fell 97.7% to $68.00 thousand from a year ago;
analysts
expected $1.00 million. 
    * Abeona Therapeutics Inc's reported EPS for the quarter was
$1.53​.
    * The mean earnings estimate of analysts had fallen by
about 24%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Abeona Therapeutics Inc shares had fallen by 9.7% this
quarter.
    * The company reported quarterly net income of $2.66
million.
    * Wall Street's median 12-month price target for Abeona
Therapeutics Inc is $29.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 29 at 01:14 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.75          1.53           Beat
 Sep. 30 2022      -1.75          -1.48          Beat
 Jun. 30 2022      -1.87          -2.08          Missed
 Mar. 31 2022      -2.37          -3.50          Missed